MarketInOut Stock Screener Log In | Sign Up

Serina Therapeutics Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Serina Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization42.42 mln
Float12.40 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

94 / 100
Top performer

Debt / Equity

0.17
Very low leverage

ROE

-265
Deeply negative

ROA

-130
Deeply negative

Business Description

Founded in 2006 and headquartered in Huntsville, Alabama, Serina Therapeutics is a medical research company focused on developing new treatments for brain and nervous system conditions, including Parkinson's disease and chronic pain. The company's work centers on its proprietary POZ platform, which is used to improve how drugs are delivered in the body, reducing unwanted immune responses while enhancing effectiveness. Serina has several programs at various stages of development, ranging from early laboratory research to completed early-phase human trials.

Key Fundamentals

EPS-1.87
ROE-265
ROIC-786
ROA-130
Interest Cover-118
EBITDA, mln-20.49
EV / EBITDA-0.25
EV / EBIT-0.25
Revenue, mln0.13
EV / Revenue39.35

Quote Details

Last 1.94
Change 0.05 (2.65%)
Open 1.47
Volume 154,895
Turnover 300,496
Average Volume 47,483

Financial Ratios

Leverage Ratio1.38
Current Ratio6.65
Price / Book2.26
Price / Tangible Book2.26
Debt / Equity0.17
Price / Sales128

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio0.56
Short % of Float0.20

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 17.58% 97 / 100   
1 Month -0.51% 56 / 100   
2 Months -7.62% 36 / 100   
6 Months 6.59% 79 / 100   
1 Year -58.81% 15 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog